Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: PER

IRD Appoints Heimo Haub to Lead Newly Formed IRD Europe GmbH


SASKATOON, SK, Dec. 6, 2021 /CNW/ - International Road Dynamics Inc. ("IRD" or the "Company"), a Quarterhill Inc. ("Quarterhill") company (TSX: QTRH) (OTCQX: QTRHF) announces that it has appointed Heimo Haub as Managing Director for IRD Europe GmbH ("IRD Europe"). Effective January 10, 2022, Mr. Haub will lead the newly formed division and will report to Rish Malhotra, CEO of IRD.

IRD Europe will operationally integrate the Belgian subsidiary ICOMS Detections as well as the recent German acquisitions Sensor Line and VDS under one organization. IRD Europe will directly service the Company's European customers and partners who will continue to benefit from IRD's high-quality products and ITS technologies that improve road safety and enhance environmental sustainability. Additionally, IRD's new and existing European customers will also benefit from receiving customer service locally.

"I am very pleased to welcome Heimo to the IRD team," said Rish Malhotra, CEO of IRD. "He has significant experience in the European ITS industry, including in the area of enforcement, a segment where IRD is a global leader today. Consolidating our European operations under his leadership will drive execution of our strategy, strengthen our presence with customers enabling them to embrace the sustainable route to improving transportation safety, and accelerate both our organic and acquisitive growth opportunities in the region."

Heimo Haub is an experienced ITS executive with a track record of more than 15 years in the industry with a focus on Commercial Vehicle Enforcement and Tolling technologies. Since 2005, Heimo has worked at EFKON, a global ITS and tolling leader based in Austria and with operations worldwide. During his career at EFKON, Heimo held leadership roles that included Head of Product Management, Technical Director and Vice President Sales, Marketing and Business Development. Heimo is well respected in the industry and has been active in Europe, Africa and Asia where his customer-oriented approach helped to expand the business and open-up new markets, such as in the Nordic region. Heimo has an MSc in Electrical Engineering and Information Technology from Technical University Graz.

"This is an exciting time to be in the ITS industry and for me to be joining IRD," said Mr. Haub. "As countries look to upgrade their infrastructure with tech-enabled solutions focused on improving safety, mobility and environmental standards, IRD is well-positioned to capitalize on this opportunity. The company has a well-respected brand, one that stands for quality, reliability and service, and has a strong foundation of operations and customers in Europe from which to grow from. I look forward to making our European journey a success story."

About IRD
IRD is a dynamic technology company engaged in developing key components and advanced systems for the next generation of transportation networks. Together with subsidiaries PAT Traffic, ICOMS Detections, SensorLine and VDS, IRD supplies Intelligent Transportation Systems (ITS) to private corporations, transportation agencies, and highway authorities around the world. IRD's systems make highways safer, greener, and more efficient. Known globally as a trusted partner providing sales, service, and installation support on major ITS projects for over 40 years, IRD contributes to creating smarter cities by empowering engineering and urban planning professionals to access reliable traffic data. For more information: www.irdinc.com

About Quarterhill
Quarterhill is a growth-oriented company in the Intelligent Transportation System (ITS) industry as well as, through its Wi-LAN Inc. subsidiary, a leader in Intellectual Property licensing. Our goal is to execute an investment strategy that capitalizes on attractive growth opportunities within ITS - and its adjacent markets - to become a global leader in that industry. Quarterhill is listed on the TSX under the symbol QTRH and on the OTCQX Best Market under the symbol QTRHF. For more information: www.quarterhill.com     

Forward-Looking Information
This news release contains forward-looking statements regarding IRD, Quarterhill and their businesses. Forward-looking statements are based on estimates and assumptions made by IRD and/or Quarterhill in light of their experience and perception of historical trends, current conditions, expected future developments and the expected effects of new business strategies, as well as other factors that IRD and/or Quarterhill believe are appropriate in the circumstances. The forward-looking events and circumstances discussed herein may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting IRD and/or Quarterhill, including: potential risks and uncertainties relating to the ultimate geographic spread of the novel coronavirus ("COVID-19"); the severity of the disease; the duration of the COVID-19 outbreak; actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact; the potential negative impacts of COVID-19 on the global economy and financial markets and any resulting impact on IRD and/or Quarterhill and/or their businesses. Other factors include, without limitation, the risks described in Quarterhill's March 11, 2021 annual information form for the year ended December 31, 2020 (the "AIF"). Copies of the AIF may be obtained at www.sedar.com. IRD and Quarterhill recommend that readers review and consider all of these risk factors and notes that readers should not place undue reliance on any of IRD's forward-looking statements. IRD has no intention, and undertakes no obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE International Road Dynamics


These press releases may also interest you

at 05:31
Ascletis Pharma Inc. (HKEX code: 1672) today announces the dosing of the first patient in the Phase III registration clinical trial of ASC40 combined with bevacizumab for treatment of recurrent glioblastoma (rGBM). ASC40 is an oral, selective...

at 04:05
Cellcom Israel Ltd. announced today that an Extraordinary General Meeting of Shareholders (the "Meeting") of Cellcom Israel Ltd. (the "Company") will be held on Monday, February 28, 2022, at 16:00 p.m. (Israel time), at the offices of the Company,...

at 04:00
Leading Dutch floating engineer Jan Willem Roe?l is internationalising his firm, FlexBase, through the launch of an international office to address global markets, in Singapore. The firm will initially focus on the Southeast Asia and subsequently the...

22 jan 2022
POWERHANDZ is a global athletic training and rehabilitation product tech company transforming the way athletes and patients improve human performance through the combined use of smart sports products, technology and services for any stage of life....

22 jan 2022
The game-changing BLUETTI AC200 power station was initially released to the public on July 1st, 2020. After pulling in a staggering $6.7M US dollars on the crowdfunding platform Indiegogo and having sold tens of thousands of units over the past year,...

22 jan 2022
Natera, Inc. , a leader in personalized genetic testing and diagnostics, today announced new data recently presented on the clinical utility of Signatera, its personalized and tumor-informed molecular residual disease (MRD) test, at the American...



News published on 6 december 2021 at 06:30 and distributed by: